There are 412 resources available
269MO - The effects of exercise on sexual health and breast cancer-specific symptom burden in women with metastatic breast cancer: Results of the multinational randomized PREFERABLE-EFFECT trial
Presenter: Martina Schmidt
Session: Mini Oral session 2
Resources:
Abstract
Webcast
270MO - An international update of the EORTC questionnaire for assessing quality of life in breast cancer patients: Results of the validation study phase IV EORTC QLQ-BR42
Presenter: Vesna Bjelic-Radisic
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
Invited Discussant 268MO, 269MO and 270MO
Presenter: Matteo Lambertini
Session: Mini Oral session 2
Resources:
Slides
Webcast
112MO - Neoadjuvant study of 12 months of abemaciclib plus letrozole vs chemotherapy in HR+/HER2– highly proliferative (Ki67=20%) breast cancer: CARABELA (GEICAM/2019-01) trial
Presenter: Miguel Martin Jimenez
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
184MO - First-in-human phase I/IIa study of the first-in-class, next-generation CDK4-selective inhibitor PF-07220060 in combination with endocrine therapy (ET) in patients (pts) with HR+/HER2- metastatic breast cancer (mBC) who progressed on prior CDK4/6 inhibitors (CDK4/6i): Safety and efficacy update
Presenter: Timothy Yap
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
113MO - NATALEE update: Safety and treatment (tx) duration of ribociclib (RIB) + nonsteroidal aromatase inhibitor (NSAI) in patients (pts) with HR+/HER2- early breast cancer (EBC)
Presenter: Carlos Barrios
Session: Mini Oral session 2
Resources:
Abstract
Slides
Webcast
Invited Discussant 112MO, 184MO and 113MO
Presenter: Yoon Sim Yap
Session: Mini Oral session 2
Resources:
Slides
Webcast
Is there a role for screening of brain metastases?
Presenter: Emilie Le Rhun
Session: Management of brain metastases from early detection to local and systemic treatments
Resources:
Webcast
How to monitor and detect endocrine resistance
Presenter: François Clément Bidard
Session: Current roles of novel endocrine therapies in the early and late settings
Resources:
Slides
Webcast
Evolving role of neurosurgery in brain metastases
Presenter: Hanno-Sebastian Meyer
Session: Management of brain metastases from early detection to local and systemic treatments
Resources:
Slides
Webcast